Synthesis and anti-hyperlipidemic evaluation of N-(benzoylphenyl)-5-fluoro- 1H-indole-2-carboxamide derivatives in Triton WR-1339-induced hyperlipidemic rats

Molecules

Volumn 15, Issue 9, 2010, Pages 5840-5849

  Shattat, Ghassan ^a   Al Qirim, Rania ^b   Al Hiari, Yusuf ^b   Sheikha, Ghassan Abu ^a   Al Qirim, Tariq ^a   El Huneidi, Waseem ^a   Shahwan, Moyad ^a  

^a AL ZAYTOONAH UNIVERSITY OF JORDAN   (Jordan)

^b UNIVERSITY OF JORDAN   (Jordan)

Author keywords

High density lipoprotein cholesterol; Hypolipidemic activity; N (benzoylphenyl) 5 fluoro 1H indole 2 carboxamides; Triglycerides; Triton WR 1339 induced hyperlipidemic rats

Indexed keywords

ANTILIPEMIC AGENT; BEZAFIBRATE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INDOLE DERIVATIVE; MACROGOL DERIVATIVE; N (BENZOYLPHENYL) 5 FLUORO 1H INDOLE 2 CARBOXAMIDE; N-(BENZOYLPHENYL)-5-FLUORO-1H-INDOLE-2-CARBOXAMIDE; TYLOXAPOL;

ANIMAL; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; HYPERLIPIDEMIA; MALE; METABOLISM; RAT; STRUCTURE ACTIVITY RELATION; SYNTHESIS; WISTAR RAT;

ANIMALS; BEZAFIBRATE; CHOLESTEROL, HDL; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; INDOLES; MALE; POLYETHYLENE GLYCOLS; RATS; RATS, WISTAR; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 77957297949     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15095840     Document Type: Article

References (27)

1. McKenney, J. M. Dyslipiemias. In Applied Therapeutics, 7th ed.; Koda-Kimble, M. A., Young, L. Y., Eds.; Lippincott Williams and Wilkins: Philadelphia, PA, USA, 2001; pp. 11:1-11:43.
2. Libby, P.; Schoenbeck, U.; Mach, F.; Selwyn, A. P.; Ganz, P. Current concepts in cardiovascular pathology: The role of LDL cholesterol in plaque rupture and stabilization. Am. J. Med. 1998, 104, 18S-27S.
3. Martin, M. J.; Hulley, S. B.; Browner, W. S.; Kuller, L. H.; Wentworth, D. Serum cholesterol, blood pressure, and mortality: implications from a cohort of 361, 662 men. Lancet 1986, 2, 933-936.
4. West, K. M.; Ahuja, M. S.; Bennet, P. H. The role of circulating glucose and triglyceride concentrations and their interactions with other "risk factors" as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care 1983, 6, 361-369.
5. Otway, S.; Robinson, D. S. The effect of the nonionic detergent (Triton) on the removal of triglyceride fatty acids from the blood of the rats. J. Physiol. 1967, 190, 309-319.
6. Schurr, P. E.; Schultz, J. R.; Parkinson T. M. Triton-induced hyperlipidemia in rats as an animal model for screening hypolipidemic drugs. Lipids 1972, 7, 69-74.
7. Hayashi, H.; Niinobe, S.; Matsumoto, Y.; Suga, T. Effects of Triton WR-1339 on lipoprotein lipolytic activity and lipid content of rat liver lysosomes. J. Biochem. 1981, 89, 573-579.
8. Frick, M. H.; Elo, O.; Haapa, K.; Heinonen, O. P.; Heinsalmi, P.; Helo, P.; Huttunen, J. K.; Kaitaniemi, P.; Koskinen, P.; Manninen, V.; Mäenpää, H.; Mälkönen, M.; Mänttäri, M.; Norola, S.; Pasternack, A.; Pikkarainen, J.; Romo, M.; Sjöblom, T.; Nikkilä, E. A. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. New Engl. J. Med. 1987, 317, 1237-1245.
9. Rubins, H. B.; Robins, S. J.; Collins, D.; Fye, C. L.; Anderson, J. W.; Elam, M. B.; Faas, F. H.; Linares, E.; Schaefer, E. J.; Schectman, G.; Wilt, T. J.; Wittes, J. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. New Engl. J. Med. 1999, 341, 410-418.
10. Schoonjans, K.; Staels, B.; Auwerx, J. Role of the peroxisome proliferator-activated receptor (PPAR) in mediating the effects of fibrates and fatty acids on gene expression. J. Lipid Res. 1996, 37, 907-925.
11. Al-Qirim, T.; Shahwan, M.; Shattat, G.; Al-Hiari, Y.; Abu Sheikha, G.; Zaidi, S. Pharmacological evaluation of novel indole-2-carboxamides as potent lipid-lowering agents in Triton-WR1339-induced hyperlipidemic rats. Z. Naturforsch. 2009, 64c, 619-625.
12. Bosies, E.; Heerdt, R.; Kuknle, H. F.; Schmidt, F. H.; Stach, H. Hypoglycemically and hypolipidemically active derivatives of phenylalkane carboxylic acids. U. S. Patent 4, 113, 871, 4 August 1976.
13. Dasseux, J.; Oniciu, C. D. Ketone compounds and compositions for cholesterol management and related uses. U. S. Patent 20, 100, 137, 444, 26 June 2009.
14. Kopin, A. S.; Carey, M.; Wang, D. Methods of altering intestinal motility and absorption of hydrophobic compounds through the use of agonists and/or antagonists of the cholecystokinin-1 receptor. U. S. Patent 224, 869, 13 September 2005.
15. Sher, P. M.; Ellsworth, B. A. Triglyceride and triglyceride-like prodrugs of glycogen phosphorylase inhibiting compounds. U. S. Patent 7098235, 13 November 2003.
16. Robichaud, L. J.; Stewart, S. F.; Adolphson, R. L. CI-922 - a novel, potent antiallergic compound. I. Inhibition of mediator release in vitro. Int. J. Immunopharmacol. 1987, 19, 41-49.
17. Olgen, S.; Coban, T. Synthesis and antioxidant properties of novel N-substituted indole-2-carboxamide and indole-3-acetamide derivatives. Arch. Pharm. 2002, 335, 331-338.
18. Liu, G.; Zhang, Z.; Luo, X.; Shen, J.; Liu, H.; Shen, X.; Chen, K.; Jiang, H. Inhibitory mode of indole-2-carboxamide derivatives against HLGPa: Molecular docking and 3D-QSAR analyses. Bioorg. Med. Chem. 2004, 15, 4147-4157.
19. Lauk, L.; Galati, E. M.; Forestieri, A. M.; Kirjavainen, S.; Trovato, A. Mucuma pruriens infusion lowers cholesterol and total lipid plasma levels in the rats. Phytother. Res. 1989, 3, 263-264.
20. Khanna, A. K.; Chauder, R.; Chandan, S.; Srivastava, A. K.; Kapoor, N. K. Hypolipidemic activity of Achyranthus aspera linn in normal and triton induces htperlipemic rats. Indian J. Exp. Biol. 1992, 30, 128-130.
21. Yamamoto, K.; Byrne, R.; Edelstein, C.; Shen, B.; Scanu, A. M. In vitro effect of Triton WR-1339 on canine plasma high density lipoproteins. J. Lipid Res. 1984, 25, 770-779.
22. Otway, S.; Robinson, D. S. The effect of the nonionic detergent (Triton) on the removal of triglyceride fatty acids from the blood of the rats. J. Physiol. 1967, 190, 309-319.
23. Campillo, J. E.; Torres, M. D.; Dominguez, E.; Romero, A.; P'erez, C. Ficus carica leaf administration reduces hypertrygliceridaemia in streptozotocin diabetic rats. Diabetologia 1994, 37, A213.
24. P'erez, C.; Canal, J. R.; Campello, J. E.; Adelaida, R.; Torres, M. D. Hypotriglyceridaemic activity of Ficus carica leaves in experimental hypertriglyceridaemic rats. Phytother. Res. 1999, 13, 188-191.
25. Malloy, M. J.; Kan, J. P. Medical management of hyperlipidemic states. Ad. Int. Med 1994, 39, 603-631.
26. Anila, L.; Vijayalakshmi, N. R. Flavonoids from Emblica officinalis and Mangifera indicaeffectiveness for dyslipidemia. J. Ethnopharmacol. 2002, 79, 81-87.
27. Staels, B.; Dallongville, J.; Auwerx, J.; Schoonjans, K.; Leitersdorf, E.; Fruchart, J. C. Mechanism of action of fibrates on lipid and lipoprotein metabolism. Circulation 1998, 98, 2088-2093.